MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Drug-Induced Liver Injury (DILI) Compound Library

MCE 站：Drug-Induced Liver Injury (DILI) Compound Library

Drug-induced liver injury (DILI; also known as drug-induced hepatotoxicity) is caused by medications (prescription or OTC), herbal ａnd dietary supplements (HDS), or other xenobiotics that result in abnormalities in liver tests or in hepatic dysfunction that cannot be explained by other causes. Drugs are an important cause of liver injury. Drug-induced hepatic injury is the most common reason cited for withdrawal of an approved drug. DILI is thought to occur via several different mechanisms. Among these are direct impairment of the structural (e.g., mitochondrial dysfunction) ａnd functional integrity of the liver; production of a metabolite that alters hepatocellular structure ａnd function; production of a reactive drug metabolite that binds to hepatic proteins to produce new antigenic drug-protein adducts, which are targeted by hosts’ defenses (the hapten hypothesis); ａnd initiation of a systemic hypersensitivity response (i.e., drug allergy) that damages the liver. MCE Drug-induced Liver Injury (DILI) Compound Library contains a unique collection of 887 hepatotoxicity causing compounds ａnd is a powerful tool to research DILI ａnd other drug toxicities. This library can be used to understand the mechanisms of DILI, identify biomarkers for early DILI prediction, ａnd allow timely recognition during drug development, thus finally achieving successful DILI prevention ａnd assessment in the pre-marketing phase.

Description & Advantages:

•   A unique collection of 887 hepatotoxicity causing compounds for high throughput screening (HTS) ａnd high content screening (HCS).

•   Including antibiotics, anti-cancer drugs, cardiac medications ａnd anti-inflammatory agent, etc.

•   A useful tool for researching drug toxicity ａnd mechanisms of DILI.

•   Including several different toxicities: steatosis, mitochondrial toxicity, cholestasis, drug allergy (hypersensitivity), etc.;

•   Structurally diverse, bioactive, ａnd cell permeable.

•   More detailed compound information with structure, IC₅₀, ａnd brief introduction.

•   NMR ａnd HPLC validated ensure high purity.

•   All compounds are in stock ａnd continuously updated.

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。